Given there was no change in NR4A2 expression in the pathological preterm placenta, we assessed whether the increased circulating levels of NR4A2 transcripts in pregnancies complicated by fetal growth restriction and preeclampsia might originate in the vasculature. The gene discussed is NR4A2; the disease is fetal growth restriction.